Dr. Vicenç Martínez Ibáñez

Head of Group
Email:  vimartin@vhebron.net
Phone: 934893098 / ext 3098

Research Group

Bioengineering, Cell Therapy and Surgery in Congenital Malformations


Since January 2015 DrVicençMartínez Ibáñez has been appointed as the Manager of the Valld’Hebron University Hospital (HUVH). Dr Martinez Ibañezhas been the Head of Pediatric Surgery Department in HUVH from 2004 to 2012 and Director of Catalan Institute of Health (ICS) form 2012 to 2015. His doctoral thesis was related to neonatal surgical stress. He has been the Spanish pioneer in hepatic pediatric transplantation in 1987, and leader in Spain of the fetal surgery program since 2001 till 2006. From 2006 to 2012 he was Chairman of surgery at the Valld’Hebron Hospital and carried out his work on fetal research as a member of the group “Bioengineering, Orthopedics and Surgery in Pediatrics” at the Research Institute of the Valld’Hebron University Hospital (VHIR).

DrMartinez Ibañezis currently coordinating the “Bioengineering, Cell Therapy and Surgery in Congenital Malformations group” at the CIBBIM-Nanomedicine and VHIR, which fosters research on new biomedical advanced therapies and nanotechnologybasedapplications for the clinical practice. In particular, stem cell therapies, new biomaterials, advanced surgical approaches, small and large animal models and preclinical validation of new therapeutic approaches in the areas of congenital malformations, neuromuscular disorders, rare diseases and regenerative medicine. Hecoauthors more than 90 papers in high impact factor journals.He is alsomember of the Board of governing and the Executive Committeemanagement of VHIR.

DrMartínez Ibáñez has been active collaborator of several research projects directly related with the study of new therapeutic approaches based in regenerative medicine for the treatment of congenital malformations, such as Spina bifida and congenital diaphragmatic hernia. He has been collaborating in Spanish and European projects involving Research centers and SME’s in which animal models are being used for preclinical validation of newtherapies for tissue engineering and regenerative medicine, and has also participated in several Randomized clinical trials (such as EuroFetus, TOTAL) for the evaluation of new therapies in human congenital malformations.DrMartínez Ibáñez is active member of several medical and scientific societies of pediatric surgery and medicine, such as Spanish society of pediatric surgery, European Union of medical specialist (UEMS) and European Pediatric Surgeons Association (EUPSA), and also participates in the editorial Board of the pediatric Surgery journal.